Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Navitas selection by the U.S. Army to develop next-generation 10 kV silicon-carbide semiconductors under the ALATTIS program is driving attention, with traders viewing the award as validation of its technology and a potential defense-market opportunity. The reaction is mixed: some expect a continued rally or short squeeze, while others note that the prototype awards value and near-term revenue impact are unclear and have pointed to the initial pop fading.

A 737 MAX flight-guidance software glitch has drawn FAA scrutiny and delayed MAX 10 certification, weighing on shares. Traders are split between viewing the issue as a fixable, previously disclosed problem and seeing it as another sign of Boeings quality and execution challenges; many dip buyers call the selloff excessive.

Kodiaks Phase 3 DAYBREAK results in wet AMD are driving attention: both Zenkuda and tabirafusp-ted met primary goals, with Zenkuda showing potential for longer intervals between injections, and the company plans an FDA filing for Zenkuda. Traders are celebrating the sharp rally and possible short squeeze, while others warn that the move may be overextended and raise concerns about cash needs and potential dilution.

RDDT is under pressure amid trader concerns that Googles publisher-payment pilot could weaken Reddits bargaining position or reduce the likelihood of a favorable AI data-licensing renewal; uncertainty around the separate Anthropic case also features in the discussion. Bears focus on deal risk and insider selling, while bulls argue Reddits user growth and data value still support the business.

A sustained selloff ahead of fiscal Q1 results has traders focused on whether Applied Digital can show progress bringing its AI data-center capacity online and converting its lease backlog into revenue. Bulls are buying the dip and looking for execution updates, while bears cite financing and dilution concerns, limited company communication, and uncertainty about the earnings reaction.

Amprius Department of Defense grant to convert a U.S. battery line for high-energy drone cells is driving attention, with bullish traders viewing it as government backing for future domestic production. Others caution that the award is not a customer order and the added capacity is years away, questioning the near-term revenue impact as the initial share-price pop faded.

Positive late-stage wet AMD results from Kodiak Sciences have intensified concerns about competition for Oculars AXPAXLI and coincided with a sharp selloff in OCUL. Traders are divided: some see the competitor data as raising the bar, while others argue the reaction is overdone and point to AXPAXLIs durability claims and planned FDA filing.

Reported talks to acquire UK digital bank Monzo are driving attention, with traders worried the costly deal could require dilution and pressure NUs shares. Others see the potential acquisition as a long-term route into the UK and Europe, though the discussions remain unconfirmed.

HBARs sharp, high-volume rally is being linked by traders to enterprise-AI developments, including an IBM Cloud identity integration and Hedera council members joining NVIDIAs Open Agent Safety Platform. Some traders instead attribute the move to momentum, a short squeeze, or crypto rotation, while others warn of profit-taking.

ACHR is drawing attention amid debate over Midnights development and execution: skeptics focus on the lack of a piloted transition and missed manufacturing goals, while bulls point to ongoing testing, flight tours, and the planned Boeing acquisitions as signs of progress. Some traders also attribute the stocks weakness to broader market and rate pressures.